Pharma-Bio Serv, Inc. (PBSV)

↓ Download CSV

CIK 0001304161 · OTC · Services-Management Consulting Services

  • Sector Services
  • Fiscal year ends Oct 31

In fiscal 2025, Pharma-Bio Serv, Inc. reported revenue of $9.00M, down 5.3% from the prior year. The company ran a net loss, with a net margin of -1.1% and a gross margin of 32.3%. It held $13.65M in total assets against $1.74M in total liabilities.

Key ratios (FY2025)

32.3%
Gross margin
-7.1%
Operating margin
-1.1%
Net margin
-0.8%
Return on equity
-5.3%
Revenue growth (YoY)
Metric (FY)2025202420232022202120202019201820172016
Revenue$9.00M$9.51M$16.98M$19.40M$20.12M$21.56M$19.51M$17.80M$13.30M
Cost of Revenue$6.09M$6.99M$11.91M$14.52M$14.76M$14.90M$13.33M$12.11M$9.46M
Gross Profit$2.91M$2.52M$5.07M$4.88M$5.36M$6.67M$6.18M$5.69M$3.84M$5.78M
Operating Income-$637.7K-$1.29M$1.12M$1.17M-$3.85M$2.23M$1.70M-$1.26M-$777.8K-$91.8K
Net Income-$100.5K-$777.6K$1.31M$1.01M-$2.09M$2.05M$2.09M$1.28M-$1.41M-$256.6K
EPS (Diluted)$-0.00$-0.03$0.06$-0.06$-0.01
Total Assets$13.65M$16.29M$19.90M$20.65M$23.92M$29.92M$26.63M$25.38M$22.35M$24.00M
Total Liabilities$1.74M$2.58M$3.78M$4.09M$5.01M$7.20M$6.03M$5.11M$1.60M$2.19M
Shareholders' Equity$11.91M$13.72M$16.13M$16.56M$18.91M$22.72M$20.61M$20.26M$20.75M$21.81M
Cash & Equivalents$14.46M$17.47M$17.14M$15.49M$16.03M$11.59M$13.77M
Operating Cash Flow-$214.9K-$566.7K$1.89M$592.5K$804.8K$1.51M-$2.21M$3.72M-$922.7K$709.7K
Capital Expenditures$6.6K$159.7K$7.3K$19.3K$10.8K$55.7K$57.4K$122.0K$57.0K$1.81M
Shares Outstanding22.91M22.96M22.96M22.94M23.00M23.00M23.00M23.06M23.09M23.01M
Dividends Per Share$0.07